[(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S,6R)-6-[(2R,3S,4R,5R,6S)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 2-aminoethyl hydrogen phosphate

Term ID

CHEBI:147804

Synonyms

Definition

References

glygen:G12185WN
glytoucan:G12185WN

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from [(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S,6R)-6-[(2R,3S,4R,5R,6S)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 2-aminoethyl hydrogen phosphate

Phenotype where environments contain [(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S,6R)-6-[(2R,3S,4R,5R,6S)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 2-aminoethyl hydrogen phosphate

Phenotype modified by environments containing [(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S,6R)-6-[(2R,3S,4R,5R,6S)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 2-aminoethyl hydrogen phosphate

Phenotype affecting [(2R,3S,4S,5S,6R)-6-[(2S,3S,4S,5S,6R)-2-[[(2R,3S,4S,5S,6R)-6-[(2R,3S,4R,5R,6S)-5-Amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 2-aminoethyl hydrogen phosphate

Human Disease Model